首页> 美国卫生研究院文献>British Medical Journal >Management of brittle diabetes with a preprogrammable implanted insulin pump delivering intraperitoneal insulin.
【2h】

Management of brittle diabetes with a preprogrammable implanted insulin pump delivering intraperitoneal insulin.

机译:用预编程的植入式腹膜内胰岛素泵治疗脆性糖尿病。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE--Glycaemic control in a young woman with "brittle" diabetes. DESIGN--Use of a preprogrammable fully implanted pump (Infusaid) to deliver insulin intraperitoneally at variable rates, giving a total dose of about 60 units/24 h. SETTING--Endocrinology department in a teaching hospital. PATIENT--Thirty year old woman with 15 years' history of "brittle" diabetes. MAIN OUTCOME MEASURES--Glycated haemoglobin concentration; plasma glucose concentration. RESULTS--After implantation of the pump there was an immediate and sustained improvement in diabetic control. The patient's glycated haemoglobin concentration decreased from 15.2% to 9.2% over seven months. Her daily glucose concentrations were in the range 3.5-12 mmol/l. She has not been admitted to hospital since implantation of the pump, which was eight months before the time of writing. CONCLUSION--The implanted programmable intraperitoneal insulin pump may be of value in the management of patients with "brittle" diabetes in whom other attempts at glycaemic control have failed.
机译:目的-一名患有“脆性”糖尿病的年轻妇女的血糖控制。设计-使用可预编程的完全植入泵(Infusaid)以可变速率腹膜内输送胰岛素,总剂量约为60单位/ 24小时。地点-教学医院内分泌科。患者-30岁的女性,有15年的“脆性”糖尿病病史。主要观察指标-糖化血红蛋白浓度;血浆葡萄糖浓度。结果-植入泵后,糖尿病控制立即得到持续改善。在七个月内,患者的糖化血红蛋白浓度从15.2%降至9.2%。她的每日葡萄糖浓度在3.5-12 mmol / l的范围内。自从植入泵以来,她还没有被送进医院,这是在撰写本文之前八个月。结论:植入式可编程腹膜内胰岛素泵可能在“脆性”糖尿病患者的治疗中有价值,这些患者在其他血糖控制尝试中均失败。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号